Skip to main content
Year archive

ArcticZymes Technologies — 2019 filings

All 56 regulatory filings released by ArcticZymes Technologies (AZT) in 2019, sourced directly from the official regulator.

56 Filings
2019 Period
2019 filings (56)
Filing Released Lang
Biotec Pharmacon ASA - Notice of Extraordinary General Meeting
AGM Information
2019-12-13 Norwegian
Biotec Pharmacon ASA - Notice of Extraordinary General Meeting
AGM Information
2019-12-13 English
Finansiell kalender
Report Publication Announcement
2019-12-12 Norwegian
Finansiell kalender
Report Publication Announcement
2019-12-12 Norwegian
Finansiell kalender
Report Publication Announcement
2019-12-12 Norwegian
Investor update presentation
Investor Presentation
2019-12-10 English
Investor update presentation
Investor Presentation
2019-12-10 English
Biotec Pharmacon ASA: Invitation to investor update presentation
AGM Information
2019-12-05 English
Biotec Pharmacon changes its strategic direction and invites shareholders to an update presentation
Regulatory Filings
2019-12-02 English
Biotec Pharmacon changes its strategic direction and invites shareholders to an update presentation
Regulatory Filings
2019-12-02 English
Biotec Pharmacon ASA - resignation of board members
Board/Management Information
2019-11-22 English
Biotec Pharmacon Q3 2019 reults
Interim / Quarterly Report Q3 2019
2019-10-24 English
Biotec Pharmacon Q3 2019 reults
Earnings Release Q3 2019
2019-10-24 English
Biotec Pharmacon ASA appoints Dr. Jethro Holter as interim CEO
Board/Management Information
2019-10-23 English
Biotec Pharmacon ASA appoints Dr. Jethro Holter as interim CEO
Board/Management Information
2019-10-23 English
Biotec Pharmacon ASA: Invitation to presentation of Q3 2019 results
Report Publication Announcement
2019-10-16 English
Biotec Pharmacon ASA: Invitation to presentation of Q3 2019 results
Report Publication Announcement
2019-10-16 English
Biotec Pharmacon ASA will present at LSX Nordic Congress
Investor Presentation
2019-08-29 English
Biotec Pharmacon ASA will present at LSX Nordic Congress
Report Publication Announcement
2019-08-29 English
Biotec Pharmacon Q2 2019 Presentation
Investor Presentation
2019-08-15 English
Biotec Pharmacon Q2 2019 Presentation
Investor Presentation
2019-08-15 English
Biotec Pharmacon Q2 2019 Report
Earnings Release Q2 2019
2019-08-15 English
Biotec Pharmacon ASA: Invitation to presentation of Q2 2019 results
Report Publication Announcement
2019-08-08 English
Biotec Pharmacon - Minutes from Annual General Meeting
AGM Information
2019-05-15 Norwegian
Biotec Pharmacon - Minutes from Annual General Meeting
AGM Information
2019-05-15 English
Biotec Pharmacon will present at Anglonordic Life Science Conference
Investor Presentation
2019-05-09 English
Biotec Pharmacon will present at Anglonordic Life Science Conference
Report Publication Announcement
2019-05-09 English
Biotec Pharmacon Q1 2019 Presentation
Investor Presentation Q1 2019
2019-04-30 English
Biotec Pharmacon Q1 2019 Presentation
Report Publication Announcement
2019-04-30 English
Biotec Pharmacon Q1 2019 Report
Interim / Quarterly Report Q1 2019
2019-04-30 English
Biotec Pharmacon Q1 2019 Report
Earnings Release Q1 2019
2019-04-30 English
Biotec Pharmacon Q1 2019 Report
Earnings Release Q1 2019
2019-04-30 English
Biotec Pharmacon enters a distribution agreement for Woulgan® in Austria
Regulatory Filings
2019-04-26 English
Biotec Pharmacon enters a distribution agreement for Woulgan® in Austria
Regulatory Filings
2019-04-26 English
Biotec Pharmacon ASA: Invitation to presentation of Q1 2019 results
Report Publication Announcement
2019-04-24 English
Biotec Pharmacon ASA - Annual report 2018
Annual Report FY 2018
2019-04-12 Norwegian
Biotec Pharmacon ASA - Annual report 2018
Report Publication Announcement
2019-04-12 English
Biotec Pharmacon ASA - Notice of Annual General Meeting
AGM Information
2019-04-12 English
Biotec Pharmacon ASA - Notice of Annual General Meeting
AGM Information
2019-04-12 English
Biotec Pharmacon renews contract with largest customer within Animal Health business
Regulatory Filings
2019-04-04 English
Biotec Pharmacon renews contract with largest customer within Animal Health business
Regulatory Filings
2019-04-04 English
Biotec Pharmacon's subsidiary, ArcticZymes, granted ?254.000 funding from Eurostars for a synthetic biology project
Regulatory Filings
2019-04-02 English
Biotec Pharmacon's subsidiary, ArcticZymes, granted ?254.000 funding from Eurostars for a synthetic biology project
Regulatory Filings
2019-04-02 English
Biotec Pharmacon - Mandatory notification of trade
Director's Dealing
2019-02-18 English
Biotec Pharmacon's subsidiary, ArcticZymes launches its first ligase enzyme
Regulatory Filings
2019-02-07 English
Biotec Pharmacon's subsidiary, ArcticZymes launches its first ligase enzyme
Regulatory Filings
2019-02-07 English
Biotec Pharmacon awarded grant from Research Council of Norway to develop next-generation wound product
Regulatory Filings
2019-02-04 English
Biotec Pharmacon awarded grant from Research Council of Norway to develop next-generation wound product
Regulatory Filings
2019-02-04 English
Financial calendar
Report Publication Announcement
2019-02-03 English
Biotec Pharmacon Q4 2018 Presentation
Investor Presentation
2019-01-30 English
Biotec Pharmacon Q4 2018 Presentation
Report Publication Announcement
2019-01-30 English
Biotec Pharmacon Q4 2018 Results
Earnings Release Q4 2018
2019-01-30 English
Biotec Pharmacon Q4 2018 Results
Earnings Release Q4 2018
2019-01-30 English
Biotec Pharmacon finalises Post Market study on Woulgan®
Regulatory Filings
2019-01-29 English
Biotec Pharmacon finalises Post Market study on Woulgan®
Environmental & Social Information
2019-01-29 English
Biotec Pharmacon ASA: Invitation to presentation of Q4 2018 results
Report Publication Announcement
2019-01-23 English